National Stock Number
6505-01-323-2649
National Stock Number (NSN) 6505-01-323-2649, or NIIN 013232649, (ceftazidime sodium in dextrose injection) was assigned July 26, 1990 in the Federal Logistics Information System (FLIS). NIIN 013232649 was cancelled on February 27, 2020, with a cancelled status of "Item is Cancelled WITHOUT Replacement." There is no known replacement specified for this stock number. This NSN does not replace any other NSNs.
There are 5 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 3 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, there are no suppliers that are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Feb 02, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 46326. [ALL EXCEPT USA]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505013232649 does not contain precious metals.
This information was last updated on May 01, 2025.